(1S,2R)-1-PHENYL-2-[(S)-1-AZIDOPROPYL]-N,N-CYCLOHEXYLENECYCLOPROPANECARBOXAMIDE
Compound with spectra: 1 NMR
![(1S,2R)-1-PHENYL-2-[(S)-1-AZIDOPROPYL]-N,N-CYCLOHEXYLENECYCLOPROPANECARBOXAMIDE](/api/compound/7ef7lUQJMhq.png?ph=true&h=300&w=458 "(1S,2R)-1-PHENYL-2-[(S)-1-AZIDOPROPYL]-N,N-CYCLOHEXYLENECYCLOPROPANECARBOXAMIDE")
| SpectraBase Compound ID | 7ef7lUQJMhq |
|---|---|
| InChI | InChI=1S/C18H24N4O/c1-2-16(20-21-19)15-13-18(15,14-9-5-3-6-10-14)17(23)22-11-7-4-8-12-22/h3,5-6,9-10,15-16H,2,4,7-8,11-13H2,1H3/t15-,16-,18+/m0/s1 |
| InChIKey | NTXYKIUMMHFUSK-XYJFISCASA-N |
| Mol Weight | 312.42 g/mol |
| Molecular Formula | C18H24N4O |
| Exact Mass | 312.195011 g/mol |
| Enantiomer InChIKey | NTXYKIUMMHFUSK-NUJGCVRESA-N |
| Copyright | Copyright © 2016-2024 W. Robien, Inst. of Org. Chem., Univ. of Vienna. All Rights Reserved. |
|---|---|
| Solvent | CDCl3 |
(1S,2R)-1-PHENYL-2-[(S)-1-AZIDOPROPYL]-N,N-CYCLOPENTYLENECYCLOPROPANECARBOXAMIDE
(1S,2R)-1-PHENYL-2-[(S)-1-AZIDOPROPYL]-N,N-DIBUTYLCYCLOPROPANECARBOXAMIDE
(1S,2R)-1-PHENYL-2-[(S)-1-AZIDOPROPYL]-N,N-DI-ISOBUTYLCYCLOPROPANECARBOXAMIDE
(1S,2R)-1-(4-FLUOROPHENYL)-2-[(S)-1-AZIDOPROPYL]-N,N-DIETHYLCYCLOPROPANECARBOXAMIDE
(1S,2R)-1-(3-FLUOROPHENYL)-2-[(S)-1-AMINOPROPYL]-N,N-DIETHYLCYCLOPROPANECARBOXAMIDE-HYDROCHLORIDE
(1S,2R)-1-(3-METHYLPHENYL)-2-[(S)-1-AMINOPROPYL]-N,N-DIETHYLCYCLOPROPANECARBOXAMIDE-HYDROCHLORIDE
(1S,2R)-1-(3-METHYLPHENYL)-2-[(S)-1-HYDROXYPROPYL]-N,N-DIETHYLCYCLOPROPANECARBOXAMIDE
DIETHYL(2-HYDROXYETHYL)METHYLAMMONIUM IODIDE, 4,4-DIPHENYL-1-ISOPROPYL-5-OXO-3-PYRROLIDINEPROPIONATE
1-[3-(4,4-DIPHENYL-1-ISOPROPYL-5-OXO-3-PYRROLIDINYL)PROPIONYL]HEXAMETHYLENEIMINE
4,4-DIPHENYL-1-ISOPROPYL-5-OXO-3-PYRROLIDINEPROPIONIC ACID, 2-(DIMETHYLAMINO)ETHYL ESTER, HYDROCHLORIDE
| Title | Journal or Book | Year |
|---|---|---|
| Synthesis of (1S,2R)-1-Phenyl-2-[(S)-1-aminopropyl]-N,N-diethylcyclopropanecarboxamide (PPDC) Derivatives Modified at the Carbamoyl Moiety As a New Class of NMDA Receptor Antagonists | Bioorganic & Medicinal Chemistry | 2002 |